Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin (Q39522079)
Jump to navigation
Jump to search
scientific article published on 17 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin |
scientific article published on 17 June 2011 |
Statements
1 reference
Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin (English)
1 reference
Renee N Donahue
1 reference
Patricia J McLaughlin
1 reference
Ian S Zagon
1 reference
17 June 2011
1 reference
1 reference
236
1 reference
7
1 reference
883-895
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference